NCT04491370
- Conditions
- B-cell Lymphoma, Burkitt Lymphoma, DNA Virus Infections, +27 more
- Locations
-
- New York Medical Center Valhalla, New York, United States
Clinical trial condition
Transformed Non-Hodgkin Lymphoma
Explore clinical trials studying Transformed Non-Hodgkin Lymphoma. Study availability and eligibility vary by location and protocol.
5 public trials
4 recruiting studies
Transformed Non-Hodgkin Lymphoma trial results
NCT06486051
- Conditions
- Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
- Locations
-
- Christchurch Hospital Christchurch, Christchurch Central, New Zealand
- Wellington Hospital Newtown, Wellington Region, New Zealand
- Auckland City Hospital Auckland, New Zealand
NCT05432635
- Conditions
- B-Cell Non-Hodgkin Lymphoma, Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, +17 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
NCT05890352
- Conditions
- Grade 3b Follicular Lymphoma, Hemic and Lymphatic Diseases, High Grade B-Cell Lymphoma, +14 more
- Locations
-
- Banner University Medical Center - Tucson Tucson, Arizona, United States
- University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
- Tower Cancer Research Foundation Beverly Hills, California, United States
- City of Hope Comprehensive Cancer Center Duarte, California, United States
Active, Not Recruiting
Nivolumab With DA-REPOCH Chemotherapy Regimen in Treating Patients With Aggressive B-Cell Non-Hodgkin's Lymphoma
NCT03749018
- Conditions
- Aggressive Non-Hodgkin Lymphoma, Ann Arbor Stage I Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma, Ann Arbor Stage II B-Cell Non-Hodgkin Lymphoma, +22 more
- Locations
-
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States